Suppr超能文献

不同批次的125碘对125I-人促卵泡生成素性质及放射配体-受体分析特性的影响。

Effects of different batches of 125iodine on properties of 125I-hFSH and characteristics of radioligand-receptor assays.

作者信息

Melson B E, Sluss P M, Reichert L E

出版信息

Anal Biochem. 1987 Feb 1;160(2):434-9. doi: 10.1016/0003-2697(87)90072-8.

Abstract

Radioiodination of highly purified human follicle-stimulating hormone (hFSH) (4000 IU/mg) was performed every other week for 23 weeks using 2 mCI carrier free Na125I (Amersham Corp., 15 mCi/micrograms I2) in the presence of lactoperoxidase. Incorporation of 125I into hFSH was determined by the method of R. C. Greenwood, W. M. Hunter, and J. S. Grover (1963) Biochem. J. 89, 114). Hormone binding was studied in vitro under steady-state conditions (16 h, 20 degrees C) using different calf testis membrane preparations having similar receptor characteristics. Each 125I-hFSH preparation was characterized for maximum bindability, specific activity of bindable radioligand as determined by self-displacement analysis, and by determination of Ka and Rt. Incorporation of 125I into FSH was relatively constant over the large number of experiments (62.4 +/- 6.4 microCi/micrograms; n = 23). By comparison, however, specific radioactivity of the receptor bindable fraction of 125I-hFSH was related to the lot of 125I utilized, and was significantly (P less than or equal to 0.01) lower and more variable (28.7 +/- 10.5 microCi/micrograms). Maximum bindability of 125I-hFSH was not correlated to specific activity (r = 0.06) but was negatively correlated to hFSH 125I incorporation (r = -0.47; P less than or equal to 0.05). These observations demonstrate the need to assess the quality of each batch of radioligand before undertaking radioligand-receptor assays and suggest that differences in Na125I lots affect specific radioactivity of the radioligand and its receptor binding characteristics.

摘要

每隔一周对高度纯化的人促卵泡激素(hFSH)(4000 IU/mg)进行放射性碘化,持续23周,使用2 mCi无载体Na125I(阿默沙姆公司,15 mCi/微克I2)并在乳过氧化物酶存在的情况下进行。采用R. C. 格林伍德、W. M. 亨特和J. S. 格罗弗(1963年,《生物化学杂志》89卷,114页)的方法测定125I掺入hFSH的情况。在稳态条件下(16小时,20℃),使用具有相似受体特征的不同小牛睾丸膜制剂进行体外激素结合研究。对每种125I-hFSH制剂进行最大结合能力、通过自置换分析确定的可结合放射性配体的比活性以及Ka和Rt测定等特性表征。在大量实验中,125I掺入FSH的情况相对恒定(62.4±6.4微居里/微克;n = 23)。然而,相比之下,125I-hFSH受体可结合部分的比放射性与所使用的125I批次有关,且显著较低(P≤0.01)且变化更大(28.7±10.5微居里/微克)。125I-hFSH的最大结合能力与比活性无关(r = 0.06),但与hFSH 125I掺入量呈负相关(r = -0.47;P≤0.05)。这些观察结果表明,在进行放射性配体-受体测定之前需要评估每批放射性配体的质量,并提示Na125I批次的差异会影响放射性配体的比放射性及其受体结合特性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验